Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT03435562
Other study ID # HM20012013
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date March 3, 2018
Est. completion date August 16, 2019

Study information

Verified date July 2020
Source Virginia Commonwealth University
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The purpose of this study is to determine differences in nicotine delivery, user behavior, subjective effects, and physiological effects, when cigarette smokers use an two new electronic cigarette devices (JUUL and IQOS) relative to their using their own brand of cigarettes.


Recruitment information / eligibility

Status Completed
Enrollment 22
Est. completion date August 16, 2019
Est. primary completion date August 16, 2019
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 21 Years to 55 Years
Eligibility Inclusion Criteria--participants must be:

- healthy (determined by self-report)

- between the ages of 18-55

- willing to provide informed consent

- able to attend the lab and abstain from tobacco/nicotine as required and must agree to use designated products according to study protocol

- cigarette smokers

Exclusion Criteria:

- Women if they are breast-feeding or test positive for pregnancy (by urinalysis) at screening.

- Individuals who weigh less than 110 pounds

Some study details about the eligibility criteria are purposely omitted at this time to preserve scientific integrity. Full details will be posted at the conclusion of the study.

Study Design


Related Conditions & MeSH terms


Intervention

Other:
JUUL electronic cigarette
Effects of JUUL electronic cigarette use.
IQOS electronic cigarette
Effects of IQOS electronic cigarette use.
Own Brand cigarette
Effects of own brand cigarette use.

Locations

Country Name City State
United States Clinical Behavioral Pharmacolgy Laboratory Richmond Virginia

Sponsors (1)

Lead Sponsor Collaborator
Virginia Commonwealth University

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Other Heart Rate Change in heart rate, measured in beats per minute Heat rate will be measured from baseline continuously throughout each each approximately 4-hr session
Other Blood Pressure Change in blood pressure, measured in mm/hg Blood pressure will be measured from baseline continuously throughout each approximately 4-hr session
Primary Change in Plasma Nicotine Change in plasma nicotine level Blood will be taken 4 times in each session: at baseline, 5 min after the start of a 10-puff product use, and then before and after an approximately 1-hour ad lib use period.
Secondary Carbon Monoxide Levels Carbon monoxide levels (in parts per mission) Carbon monoxide levels will be assessed before and after product use in each approximately 4-hr session: at baseline, 5 min after the end of a 10-puff product use, and then before and after an approximately 1-hour ad lib use period.
Secondary Tiffany-Drobes Questionnaire of Smoking Urges - Factor 1 This scale is used to assess the extent to which product use reduces the intention to smoke a cigarette, and consists of 5 items that are scored 0 - 7, in which participants clicked seven discrete ratings from 'not at all' to 'extremely'. The items are summed and scores range from 0 to 30 with higher scores indicating higher craving for a cigarette. Questionnaire will be administered 4 times in each each approximately 4-hr session: before any product use, 10 minutes after the start of a 10-puff use bout, and then before and after an approximately 1-hour ad lib use period.
Secondary Tiffany-Drobes Questionnaire of Smoking Urges - Factor 2 This scale is used to assess the extent to which product use reduces the intention to smoke a cigarette, and consists of 4 items that are scored 0 - 7, in which participants clicked seven discrete ratings from 'not at all' to 'extremely'. The items are summed and scores range from 0 to 24 with higher scores indicating higher craving for a cigarette. Questionnaire will be administered 4 times in each each approximately 4-hr session: before any product use, 10 minutes after the start of a 10-puff use bout, and then before and after an approximately 1-hour ad lib use period.
Secondary Hughes-Hatsukami Questionnaire - Anxious This scale is used to assess the extent to which product use affects on anxiety and consists of 1 item scored 0 - 100 with 0 being not at all and 100 being extremely. Questionnaire will be administered 4 times in each approximately 4-hr session: before any product use, 10 minutes after the start of a 10-puff use bout, and then before and after an approximately 1-hour ad lib use period.
Secondary Hughes-Hatsukami Questionnaire - Craving This scale is used to assess the extent to which product use affects on craving a cigarette and consists of 1 item scored 0 - 100 with 0 being not at all and 100 being extremely. Questionnaire will be administered 4 times in each approximately 4-hr session: before any product use, 10 minutes after the start of a 10-puff use bout, and then before and after an approximately 1-hour ad lib use period.
Secondary Hughes-Hatsukami Questionnaire - Depression This scale is used to assess the extent to which product use affects on depression and consists of 1 item scored 0 - 100 with 0 being not at all and 100 being extremely. Questionnaire will be administered 4 times in each approximately 4-hr session: before any product use, 10 minutes after the start of a 10-puff use bout, and then before and after an approximately 1-hour ad lib use period.
Secondary Hughes-Hatsukami Questionnaire - Difficulty Concentrating This scale is used to assess the extent to which product use affects having difficulty concentrating and consists of 1 item scored 0 - 100 with 0 being not at all and 100 being extremely. Questionnaire will be administered 4 times in each approximately 4-hr session: before any product use, 10 minutes after the start of a 10-puff use bout, and then before and after an approximately 1-hour ad lib use period.
Secondary Hughes-Hatsukami Questionnaire - Drowsy This scale is used to assess the extent to which product use affects feeling drowsy and consists of 1 item scored 0 - 100 with 0 being not at all and 100 being extremely. Questionnaire will be administered 4 times in each approximately 4-hr session: before any product use, 10 minutes after the start of a 10-puff use bout, and then before and after an approximately 1-hour ad lib use period.
Secondary Hughes-Hatsukami Questionnaire - Hunger This scale is used to assess the extent to which product use affects reducing hunger and consists of 1 item scored 0 - 100 with 0 being not at all and 100 being extremely. Questionnaire will be administered 4 times in each approximately 4-hr session: before any product use, 10 minutes after the start of a 10-puff use bout, and then before and after an approximately 1-hour ad lib use period.
Secondary Hughes-Hatsukami Questionnaire - Impatient This scale is used to assess the extent to which product use affects feeling impatient and consists of 1 item scored 0 - 100 with 0 being not at all and 100 being extremely. Questionnaire will be administered 4 times in each approximately 4-hr session: before any product use, 10 minutes after the start of a 10-puff use bout, and then before and after an approximately 1-hour ad lib use period.
Secondary Hughes-Hatsukami Questionnaire - Irritable This scale is used to assess the extent to which product use affects feeling irritable and consists of 1 item scored 0 - 100 with 0 being not at all and 100 being extremely. Questionnaire will be administered 4 times in each approximately 4-hr session: before any product use, 10 minutes after the start of a 10-puff use bout, and then before and after an approximately 1-hour ad lib use period.
Secondary Hughes-Hatsukami Questionnaire - Restless This scale is used to assess the extent to which product use affects feeling restless and consists of 1 item scored 0 - 100 with 0 being not at all and 100 being extremely. Questionnaire will be administered 4 times in each approximately 4-hr session: before any product use, 10 minutes after the start of a 10-puff use bout, and then before and after an approximately 1-hour ad lib use period.
Secondary Hughes-Hatsukami Questionnaire - Desire for Sweets This scale is used to assess the extent to which product use affects having desire for sweets and consists of 1 item scored 0 - 100 with 0 being not at all and 100 being extremely. Questionnaire will be administered 4 times in each approximately 4-hr session: before any product use, 10 minutes after the start of a 10-puff use bout, and then before and after an approximately 1-hour ad lib use period.
Secondary Hughes-Hatsukami Questionnaire - Urge to Smoke This scale is used to assess the extent to which product use affects having the urge to smoke and consists of 1 item scored 0 - 100 with 0 being not at all and 100 being extremely. Questionnaire will be administered 4 times in each approximately 4-hr session: before any product use, 10 minutes after the start of a 10-puff use bout, and then before and after an approximately 1-hour ad lib use period.
Secondary Direct Effects of Nicotine Questionnaire - Awake One question is used to assess how much product use makes participants feel awake, and is scored 0 (not at all) to 100 (extremely). Questionnaire will be administered 4 times in each each approximately 4-hr session: before any product use, 10 minutes after the start of a 10-puff use bout, and then before and after an approximately 1-hour ad lib use period.
Secondary Direct Effects of Nicotine Questionnaire - Calm One question is used to assess how much product use makes participants feel calm, and is scored 0 (not at all) to 100 (extremely). Questionnaire will be administered 4 times in each each approximately 4-hr session: before any product use, 10 minutes after the start of a 10-puff use bout, and then before and after an approximately 1-hour ad lib use period.
Secondary Direct Effects of Nicotine Questionnaire - Concentrate One question is used to assess how much product use helps participants concentrate, and is scored 0 (not at all) to 100 (extremely). Questionnaire will be administered 4 times in each each approximately 4-hr session: before any product use, 10 minutes after the start of a 10-puff use bout, and then before and after an approximately 1-hour ad lib use period.
Secondary Direct Effects of Nicotine Questionnaire - Dizzy One question is used to assess how much product use makes participants feel dizzy, and is scored 0 (not at all) to 100 (extremely). Questionnaire will be administered 4 times in each each approximately 4-hr session: before any product use, 10 minutes after the start of a 10-puff use bout, and then before and after an approximately 1-hour ad lib use period.
Secondary Direct Effects of Nicotine Questionnaire - Reduce Hunger One question is used to assess how much product use reduces feeling of hunger, and is scored 0 (not at all) to 100 (extremely). Questionnaire will be administered 4 times in each each approximately 4-hr session: before any product use, 10 minutes after the start of a 10-puff use bout, and then before and after an approximately 1-hour ad lib use period.
Secondary Direct Effects of Nicotine Questionnaire - Sick One question is used to assess how much product use makes participants feel sick, and is scored 0 (not at all) to 100 (extremely). Questionnaire will be administered 4 times in each each approximately 4-hr session: before any product use, 10 minutes after the start of a 10-puff use bout, and then before and after an approximately 1-hour ad lib use period.
Secondary Direct Effects of Product Use Questionnaire - Pleasant A single question is used to assess if product use felt pleasant, and is scored 0 (not at all) to 100 (extremely). Questionnaire will be administered 2 times in each each approximately 4-hr session: 10 minutes after the start of a 10-puff use bout, and then after an approxiamtely 1-hour ad lib use period.
Secondary Direct Effects of Product Use Questionnaire - Taste Good A single question is used to assess if product use tasted good, and is scored 0 (not at all) to 100 (extremely). Questionnaire will be administered 2 times in each each approximately 4-hr session: 10 minutes after the start of a 10-puff use bout, and then after an approxiamtely 1-hour ad lib use period.
Secondary Direct Effects of Product Use Questionnaire - Satisfying A single question is used to assess if product use felt satisfying, and is scored 0 (not at all) to 100 (extremely). Questionnaire will be administered 2 times in each each approximately 4-hr session: 10 minutes after the start of a 10-puff use bout, and then after an approxiamtely 1-hour ad lib use period.
Secondary Direct Effects of Product Use Questionnaire - Smoke Right Now A single question is used to assess if product use made them want to use the product again right now, and is scored 0 (not at all) to 100 (extremely). Questionnaire will be administered 2 times in each each approximately 4-hr session: 10 minutes after the start of a 10-puff use bout, and then after an approxiamtely 1-hour ad lib use period.
See also
  Status Clinical Trial Phase
Completed NCT03194256 - Evaluating New Nicotine Standards for Cigarettes - Project 3 N/A
Recruiting NCT05587504 - Determination of Liquid Flavor and Nicotine Form Outcomes N/A
Completed NCT03284632 - e-Cigarette - DNA Adducts
Terminated NCT03830892 - Effects of E-Cigarette Power and Nicotine Content in Dual Users and Vapers N/A
Completed NCT03710590 - Effects of Electronic Cigarette Settings and Liquid Concentrations in Cigarette Smokers and Electronic Cigarette Users N/A
Completed NCT03098004 - Effects of e-Cigarettes on Nicotine Withdrawal N/A
Completed NCT03861078 - The Effect of Electronic Cigarette Liquid Characteristics in Smokers. N/A
Completed NCT03742817 - Effects of e-Cigarettes on Perceptions and Behavior N/A